Innovative methods of treating drug-resistant epilepsy
Review of the latest reports
DOI:
https://doi.org/10.12775/QS.2025.43.61441Keywords
drug-resistant epilepsy, treatment of epilepsy, brain stimulation, epilepsy surgery, ketogenic dietAbstract
Information and purpose: Drug-resistant epilepsy (DRE) affects about one-third of epilepsy patients, posing a serious challenge despite numerous available antiepileptic drugs. For patients who do not respond to pharmacological treatment, alternative approaches are needed. This study aims to present selected non-pharmacological methods for treating DRE.
Material and methods: The review is based on publicly available sources, focusing on articles published between 2020 and 2025 in the PubMed database. Historical context was drawn from literature dating back to the 1990s.
Results: Common non-pharmacological treatments include surgery, neurostimulation, and the ketogenic diet. These methods have proven effective in reducing seizure frequency and improving quality of life. They offer personalized and well-tolerated options suitable for different age groups.
Conclusions: Non-pharmacological treatments for DRE are valuable alternatives for patients not benefiting from medication. Their efficacy and safety support their growing use in modern clinical practice.
References
[1] Kwan P, Arzimanoglu A, Berg AT, Brodie MJ, Hauser WA, Mathern G, Moshe SL, Perucca E, Wlebe S, French J. Definition of drug resistant epilepsy: Cpmmision on Therapeutic Strategies, Special Report. Epilepsia 2009. http://doi.org10.1111/j.1528-1167.2009.02397.x
[2]Sabzvari T, Iqbal MA, Ranganatha A, Daher JC, Freire I, Maham S, Shamsi F, Anthony O.V.P, Hingorani AG, Sinha AS, Nazir Z, Shamsi F. A Comprehensive Review of Recent Trends in Surgical Approaches for Epilepsy Management. Cureus. 2024 Oct 17;16(10):e71715. PMID: 39553057. PMCID: PMC11568833. http://doi.org/10.7759/cureus.71715
[3] Schmitz B, Lattanzi S, Vonck K, Kalviainen R, Nashef L, Ben-Menachem E. Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations. Epilepsia Open. 2023 Oct 3;8(4):1241–1255. PMID: 37743544. PMCID: PMC10690671. http://doi.org/10.1002,/epi4.12830
[4] Yang Y, Shangguan Y, Wang X, Liu R, Shen Z, Tang M, Jiang G. The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study. Front Neurol 2024 Jan 9;14:1307296. PMID: 38264091. PMCID: PMC10804851 http://doi.org10.3389/fneur.2023.1307296
[5] Rola R.: The use of deep brain stimulation as an alternative treatment for drug-resistant epilepsy. Neurol Prakt 2012, 2(65), 7-10. Polish.
[6] Zhong C, Yang K, Wang N, Yang L, Yang Z, Xu L, Wang J, Zhang L. Advancements in Surgical Therapies for Drug-Resistant Epilepsy: A Paradigm Shift towards Precision Care. Neurol Ther. 2025 Feb 10;14(2):467–490. PMCID:PMC11906941 PMID: 39928287 http://doi.org10.1007/s40120-025-00710-4
[7] Goodale SE, González HFJ, Johnson GW, Gupta K, Rodriguez WJ, Shults R, Rogers BP, Rolston JD, Dawant BM, Morgan VL, Englot DJ. Resting-State SEEG May Help Localize Epileptogenic Brain Regions. Neurosurgery. 2019 Sep 16;86(6):792–801. PMCID: PMC7225010 PMID: 31814011. http://doi.org10.1093/neuros/nyz351
[8] Jehi L, Morita-Sherman M, Love TE, Bartolomei F, Bingaman W, Braun K, Busch R, Duncan J, Hader WJ, Luan G, Rolston JD, Schuele S, Tassi L, Vadera S, Sheikh S, Najm I, Arain A, Bingaman J,Diehl B,de Tisi J, Rados M, Van Eijsden P, Wahby S, Wang X, Wiebe S. Comparative Effectiveness of Stereo-EEG versus Subdural Grids in Epilepsy Surgery. Ann Neurol PMID: 34590337 PMCID: PMC9438788. http://doi.org10.1002/ana.26238
[9]Medina-Pizarro M, Spencer DD, Damisah EC. Recent advances in epilepsy surgery. Curr Opion Neurol. 2023 Apr 1;36(2):95-101. http://doi.org10.1097/WCO.0000000000001134
[10]Kerezoudis P, Parisi V, Marsh WR, Kaufman TJ, Lehman VT, Worrell GA, Miller KJ, Gompel JJV. Surgical Outcomes of Laser Interstitial Thermal Therapy for Temporal Lobe Epilepsy: Systematic Review and Meta-analysis. World Neurosurg. 2020 Nov:143:527-536.e3. PMID: 32750511. http://doi.org10.1016/j.wneu.2020.07.194
[11] Youngerman BE, Banu MA, Khan F, McKhann GM, Schevon CA, Jagid, Cajigas I ,Theodotou CB, Ko A, Buckley R, Ojemann JG, Miller JW, Laxton AW, Couture DE, Popli GS, Buch VP, Halpern CH, Le S, Sharan AD, Sperling MR, Mehta AD, Englot DJ, Neimat JS, Konrad PE, Sheth SA, Neal EG, Vale FL, Holloway KL, Air EL, Schwalb JM, D'Haese PF, Wu C. Long-term outcomes of mesial temporal laser interstitial thermal therapy for drug-resistant epilepsy and subsequent surgery for seizure recurrence: a multi-centre cohort study. J Neurol Neurosurg Psychiatry. 2023 Nov;94(11):879-886. PMID: 37336643 PMCID: PMC10776034. http://doi.org10.1136/jnnp-2022-330979
[12] Bottan JS, Almalki F, Nouri MN, Lau JC, Iansavichene AI, Gilmore G, Miller M, de Ribaupierre S, Andrade AV. Radiofrequency-thermocoagulation in pediatric epilepsy surgery: A systematic review and pooled analysis of cases. Seizure. 2025 Mar:126:6-13. PMID: 39874864. http://doi.org10.1016/j.seizure.2025.01.012
[13] Austelle CW, Cox SS, Wills KE, Badran B. Vagus nerve stimulation (VNS): recent advances and future directions. Clin Auton Res. 2024 Oct 4;34(6):529–547. PMID: 39363044. PMCID: PMC11543756 . http://doi.org10.1007/s10286-024-01065-w
[14] Gouveia FV, Warsi NM, Suresh H, Matin R, Ibrahim GM. Neurostimulation treatments for epilepsy: Deep brain stimulation, responsive neurostimulation and vagus nerve stimulation. Neurotherapeutic. 2024 Jan 4;21(3):e00308. PMID: 38177025. PMCID: PMC11103217. http://doi.org10.1016/j.neurot.2023.e00308
[15] Mandalaneni K, Rayi A. Vagus Nerve Stimulator. StatPearls Publishing. August 7, 2023
[16] Austelle CW, Cox SS, Wills KE, Badran B. Vagus nerve stimulation (VNS): recent advances and future directions. Clin Auton Res. 2024 Oct 4;34(6):529–547. PMID: 39363044. PMCID: PMC11543756. http://doi.org10.1007/s10286-024-01065-w
[17] Ben-Menachem E, Manon-Espaillat R, Ristanovic R, Wilder BJ, Mirza W, Tarver WB, Wernicke JF. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Clinical Trial. 1994 May-Jun;35(3):616-26. PMID: 8026408.http://doi.org10.1111/j.1528-1157.1994.tb02482.x.
[18] Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, Labar DR, Morris 3rd GL, Salinsky MC, Osorio I, Ristanovic RK, Labiner DM, Jones JC, Murphy JV, Ney GC, Wheless JW. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Clinical Trial. 1998 Jul;51(1):48-55. PMID: 9674777. http://doi.org10.1212/wnl.51.1.48.
[19] Scherrmann J , Hoppe C, Kral T, Schramm J, Elger CE. Vagus nerve stimulation: clinical experience in a large patient series. Clinical trial. 2001 Sep;18(5):408-14. PMID: 11709645. http://doi.org10.1097/00004691-200109000-00004.
[20] Jain P , Arya R. Vagus Nerve Stimulation and Seizure Outcomes in Pediatric Refractory Epilepsy: Systematic Review and Meta-analysis. Neurology. 2021 May 31;96(22):1041-1051 http://doi.org10.1212/WNL.0000000000012030
[21] Yang H, Shi W, Fan J, Wang X, Song Y, Lian Y, Shan W, Wang Q. Transcutaneous Auricular Vagus Nerve Stimulation (ta-VNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial. Neurotherapeutics. 2023 Mar 30;20(3):870–880. http://doi.org10.1007/s13311-023-01353-9
[22] Rola R. The use of deep brain stimulation as an alternative in the treatment of drug-resistant epilepsy. Neurol Prakt 2012, 2(65), 7-10
[23] Fabriba KA, Gupta V. Deep Brain stimulation. StatPearls. July 24, 2023
[24] Salanova V, Witt T , Worth R, Henry TR , Gross RE, Nazzaro JM , Labar D , Sperling MR , Sharan A , Sandok E, Handforth A, Stern JM , Chung S , Henderson JM , French J , Baltuch G , Rosenfeld WE , Garcia P , Barbaro NM , Fountain NB , Elias WJ , Goodman RR , Pollard JR , Tröster AI , Irwin CP , Lambrecht K , Graves N , Robert Fisher , SANTE Study Group. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Randomized Controlled Trial, Neurology. 2015 Mar 10;84(10):1017-25. PMID: 25663221. PMCID: PMC4352097. http://doi.org10.1212/WNL.0000000000001334.
[25] Gouveia FV, Warsi NM, Suresh H, Matin R, Ibrahim GM. Neurostimulation treatments for epilepsy: Deep brain stimulation, responsive neurostimulation and vagus nerve stimulation. Neurotherapeutics. 2024 Jan 4;21(3):e00308. PMID: 38177025. PMCID: PMC11103217. http://doi.org10.1016/j.neurot.2023.e00308
[26] Salanova V, Witt T , Worth R, Henry TR , Gross RE, Nazzaro JM , Labar D , Sperling MR , Sharan A , Sandok E, Handforth A, Stern JM , Chung S , Henderson JM , French J , Baltuch G , Rosenfeld WE , Garcia P , Barbaro NM , Fountain NB , Elias WJ , Goodman RR , Pollard JR , Tröster AI , Irwin CP , Lambrecht K , Graves N , Robert Fisher , SANTE Study Group. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Randomized Controlled Trial, Neurology. 2015 Mar 10;84(10):1017-25. PMID: 25663221. PMCID: PMC4352097. http://doi.org10.1212/WNL.0000000000001334.
[27] Salanova V, Sperling MR , Gross RE , Irwin CP , Vollhaber JA , Giftakis JE, Fisher RS. The SANTÉ study at 10 years of follow-up: Effectiveness, safety, and sudden unexpected death in epilepsy. Randomized Controlled Trial, Epilepsy. 2021 Jun;62(6):1306-1317. PMID: 33830503. http://doi.org10.1111/epi.16895
[28] Kaufmann E, Peltola J , Colon AJ , Lehtimäki K , Majtanik M, Mai JK, Bóné B, Bentes C, Coenen V, Gil-Nagel A, Goncalves-Ferreira AJ, Ryvlin P, Taylor R, Brionne T, Gielen F, Song S, Boon P; MORE study group. Long-term evaluation of anterior thalamic deep brain stimulation for epilepsy in the European MORE registry. Epilepsja. 2024 Aug;65(8):2438-2458. http://doi.org10.1111/epi.18003.
[29] Raslan EE, Al-Hawas SF, Alghamdi MM, Alblwan AS, Alhomaidhi A, Alruwaili AA, Warar R, Alhwaiti AS, Alsubhi RM, Al-harbi WF, Alasmari MN. Assessment of the Efficacy of Deep Brain Stimulation (DBS) in Managing Drug-Resistant Epilepsy (DRE): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs). Cureus. 2024 Oct 13;16(10):e71348. PMCID: PMC11555489 PMID: 39534832. http://doi.org10.7759/cureus.71348
[30] Gouveia FV, Warsi NM, Suresh H, Rafi Matin R, Ibrahim GM. Neurostimulation treatments for epilepsy: Deep brain stimulation, responsive neurostimulation and vagus nerve stimulation. Neurotherapeutics. 2024 Jan 4;21(3):e00308. PMCID:PMC11103217 PMID: 38177025 http://doi.org10.1016/j.neurot.2023.e00308
[31] Mushtaq O, Grezenko H, Rehman A, Sher H, Sher Z, Kaakyire DA, Hanifullah S, Dabas M, Saleh G, Shehryar A, Khan I. Role of Responsive Neurostimulation in Managing Drug-Resistant Epilepsy: A Systematic Review of Clinical Outcomes. Cureus. 2024 Aug 28;16(8):e68032. PMCID:PMC11431993 PMID: 39347167. http://doi.org10.7759/cureus.68032
[32] Jarosiewicz B, Morell M. The RNS System: brain-responsive neurostimulation for the treatment of epilepsy. Expert Review of Medical Devices. 24 May 2019, Accepted 18 Oct 2019. https://doi.org/10.1080/17434440.2019.1683445
[33] Ghosh S, Sinha JK, Ghosh S, Sharma H, Bhaskar R, Narayanan KB. A Comprehensive Review of Emerging Trends and Innovative Therapies in Epilepsy Management. Brain Sci. 2023 Sep 11;13(9):1305. PMCID: PMC10527076 PMID: 37759906 http://doi.org10.3390/brainsci13091305
[34] Kusyk D, Meinert J, Stabingas KC, Yin Y, Whiting AC. Systematic Review and Meta-Analysis of Responsive Neurostimulation in Epilepsy. Meta-Analysis, Word Neurosurg. 2022 Nov:167:e70-e78. PMID: 35948217. http://doi.org10.1016/j.wneu.2022.07.147
[35] Yang Y, Wei P, Shi J , Mao Y, Zhang J, Ding Lei 4, Yang Z , Song S , Qian R , Li W, Shan Y , Zhao G. Early assessment of responsive neurostimulation for drug-resistant epilepsy in China: A multicenter, self-controlled study. Randomized Controlled Trial, Chin Med. J. 2025 Feb 20;138(4):430-440. PMID: 39593204PMCID: PMC11845213. http://doi.org10.1097/CM9.0000000000003292
[36] Levy AS, Bystrom LL, Brown EC, Fajardo M, Wang S. Responsive neurostimulation for treatment of pediatric refractory epilepsy: A pooled analysis of the literaturę. Clin Neurol Neurosurg. 2023 Nov:234:108012. PMID: 37839147. http://doi.org10.1016/j.clineuro.2023.108012.
[37] Panov F, Ganaha S, Haskell J , Fields M, Vega-Talbott ML, Wolf S , McGoldrick P , Marcuse L, Ghatan S. Safety of responsive neurostimulation in pediatric patients with medically refractory epilepsy. J Neurosurg Pediatr. 2020 Nov 5;26(5):525-532. http://doi.org10.3171/2020.5.PEDS20118.
[38] Zhou C, Wang M , Liang J, G. G4, Ning Chen. Ketogenic Diet Benefits to Weight Loss, Glycemic Control, and Lipid Profiles in Overweight Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trails. Int J Environ Res Public Health. 2022 Aug 22;19(16):10429. PMCID: PMC9408028 PMID: 36012064. http://doi.org10.3390/ijerph191610429
[39] Ghosh S, Sinha JK, Ghosh S, Sharma H, Bhaskar R, Narayanan KB. A Comprehensive Review of Emerging Trends and Innovative Therapies in Epilepsy Management. Brain Sci. 2023 Sep 11;13(9):1305. PMCID:PMC10527076 PMID: 37759906. http://doi.org10.3390/brainsci13091305
[40] Mutarelli A, Nogueira A, Felix N, Dagostin KS, Martins Castro LH, Mota Telles JP. Modified Atkins diet for drug-resistant epilepsy: A systematic review and meta-analysis of randomized controlled trials. Seizure, 2023 Nov:112:77-83. PMID: 37769548. http://doi.org10.1016/j.seizure.2023.09.010.
[41] Kishk NA, Yousof HZ, Ebraheim AM, Ali Elkholy TA, Soliman SH, Mohammed RA, Shamloul RM. The effect of ketogenic diet escalation in adolescents and adults with drug-resistant epilepsy: a prospective study. Nutr Neurosci. 2022 Oct;25(10):2023-2032. http://doi.org10.1080/1028415X.2021.1927604
[42] Manral M, Dwivedi R, Gulati S, Kaur K, Nehra A, Pandey RM , Upadhyay AD, Sapra S, Tripathi M. Safety, Efficacy, and Tolerability of Modified Atkins Diet in Persons With Drug-Resistant Epilepsy: A Randomized Controlled Trial. Neurology. 2023 Mar 28;100(13):e1376-e1385. PMID: 36599697 PMCID: PMC10065201. 2023 Mar 28;100(13):e1376-e1385. http://doi.org10.1212/WNL.0000000000206776
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Patrycja Fatyga, Wiktoria Fatyga, Piotr Kowalik, Gabriela Pabis, Joanna Wziątek, Paula Bętkowska, Iwona Koziołek, Magdalena Strzelczyk, Daria Krzyżanowska, Kinga Dowierciał
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 357
Number of citations: 0
